Literature DB >> 16899456

Bisandrographolide from Andrographis paniculata activates TRPV4 channels.

Paula L Smith1, Katherine N Maloney, Randy G Pothen, Jon Clardy, David E Clapham.   

Abstract

Many transient receptor potential (TRP) channels are activated or blocked by various compounds found in plants; two prominent examples include the activation of TRPV1 channels by capsaicin and the activation of TRPM8 channels by menthol. We sought to identify additional plant compounds that are active on other types of TRP channels. We screened a library of extracts from 50 Chinese herbal plants using a calcium-imaging assay to find compounds active on TRPV3 and TRPV4 channels. An extract from the plant Andrographis paniculata potently activated TRPV4 channels. The extract was fractionated further, and the active compound was identified as bisandrographolide A (BAA). We used purified compound to characterize the activity of BAA on certain TRPV channel subtypes. Although BAA activated TRPV4 channels with an EC(50) of 790-950 nm, it did not activate or block activation of TRPV1, TRPV2, or TRPV3 channels. BAA activated a large TRPV4-like current in immortalized mouse keratinocytes (308 cells) that have been shown to express TRPV4 protein endogenously. This compound also activated TRPV4 currents in cell-free outside-out patches from HEK293T cells overexpressing TRPV4 cDNA, suggesting that BAA can activate the channel in a membrane-delimited manner. Another related compound, andrographolide, found in abundance in the plant Andrographis was unable to activate or block activation of TRPV4 channels. These experiments show that BAA activates TRPV4 channels, and we discuss the possibility that activation of TRPV4 by BAA could play a role in some of the effects of Andrographis extract described in traditional medicine.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16899456     DOI: 10.1074/jbc.M605394200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

Review 1.  International Union of Basic and Clinical Pharmacology. LXXVI. Current progress in the mammalian TRP ion channel family.

Authors:  Long-Jun Wu; Tara-Beth Sweet; David E Clapham
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

2.  Forward genetic analysis reveals multiple gating mechanisms of TRPV4.

Authors:  Stephen Loukin; Zhenwei Su; Xinliang Zhou; Ching Kung
Journal:  J Biol Chem       Date:  2010-04-27       Impact factor: 5.157

3.  Nociceptive and pro-inflammatory effects of dimethylallyl pyrophosphate via TRPV4 activation.

Authors:  S Bang; S Yoo; T J Yang; H Cho; S W Hwang
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

Review 4.  TRPs and pain.

Authors:  Yi Dai
Journal:  Semin Immunopathol       Date:  2015-09-15       Impact factor: 9.623

Review 5.  Transient receptor potential (TRP) channels as drug targets for diseases of the digestive system.

Authors:  Peter Holzer
Journal:  Pharmacol Ther       Date:  2011-03-21       Impact factor: 12.310

Review 6.  TRP channels as candidates for hearing and balance abnormalities in vertebrates.

Authors:  Math P Cuajungco; Christian Grimm; Stefan Heller
Journal:  Biochim Biophys Acta       Date:  2007-01-17

Review 7.  From chills to chilis: mechanisms for thermosensation and chemesthesis via thermoTRPs.

Authors:  Michael Bandell; Lindsey J Macpherson; Ardem Patapoutian
Journal:  Curr Opin Neurobiol       Date:  2007-08-13       Impact factor: 6.627

Review 8.  Transient receptor potential (TRP) channels: a clinical perspective.

Authors:  Yosuke Kaneko; Arpad Szallasi
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

9.  The TRPV4 cation channel: A molecule linking skin temperature and barrier function.

Authors:  Takaaki Sokabe; Makoto Tominaga
Journal:  Commun Integr Biol       Date:  2010-11-01

Review 10.  Calcium influx pathways in breast cancer: opportunities for pharmacological intervention.

Authors:  I Azimi; S J Roberts-Thomson; G R Monteith
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.